Views & Analysis Words matter during a heart attack Recent research suggests that the ways in which men and women describe heart attack symptoms differently can affect diagnosis in urgent situations.
News Novartis' canakinumab cuts risk for heart attack survivors Novartis to discuss canakinumab results with regulators.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face